Compare General Motors Company (GM) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Motors Company vs Intuitive Surgical, Inc. — how do they compare? General Motors Company trades at $82.73 (market cap $72.17B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 2× General Motors Company's market cap, and General Motors Company pays a 0.88% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Motors Company for 83 Days and Intuitive Surgical, Inc. for 84 Days on average.
| GM | ISRG | |
|---|---|---|
Market Cap | $72.17B | $146.76B |
Volume | 4,900,304 | 2,529,814 |
Sector | Consumer Cyclical | Health |
52-Week High | $90.30 | $592.85 |
52-Week Low | $55.35 | $332.02 |
Typical Hold Time | 83 Days | 84 Days |
Enterprise Value | $175.15B | $141.54B |
Dividend Yield | 0.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Motors (GM) trades at $82.25, up 1.56% with a bearish technical signal despite recent earnings beats. The company shows mixed fundamentals with strong cash flow ($26.9B operating cash flow in 2025) but declining profit margins (1.05% net margin). Recent Q3 2026 sales declined 5.5% as EV demand weakens, though regulatory savings of $20.4B through 2031 provide some offset. Analyst consensus remains bullish with a $102.08 price target representing 24% upside potential.
GM faces near-term headwinds from declining vehicle sales and margin pressure, but long-term value exists through cost savings initiatives and strong cash generation. The stock trades at attractive valuations (P/S 0.42x) with 67% analyst buy ratings, though competitive pressure from Asian automakers and EV transition challenges present significant execution risks for investors.
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
